“How to Play Genomics for Potential Triple-Bagger Gains”

Marc Lichtenfeld, who we’ve covered a number of times in this space, focuses largely on biotech investments — he’s teased a number of them for a variety of different newsletters that he has helmed or contributed to, but it looks like he’s now launching a new letter from the Oxford Club called FirstLine Investor Alert. [...]

FirstLine Investor Alert

Biotech-focused newsletter from Lichtenfeld, who previously edited the similar-sounding Access Group letters for White Cap Research.

“Energy Armageddon Coming to America” and some updates on old favorites

We’ll be skipping almost all publishing next week, including the Friday File, as Stock Gumshoe closes down for a few days for vacation and redesign prep on the new and improved StockGumshoe.com — so I’ll try to make this one good enough to last a couple weeks for you! The new site, in case you’re [...]

“Starting On November 1, this ‘Can’t Lose’ Tech Stock Will Crash and Burn”

I always like to write about a bear case on a stock, or a put-buying or short-selling teaser, because they’re so rare — most people wouldn’t consider shorting stocks because of the different risk profile and the unfamiliar process, and many folks even think there’s something vaguely un-American about betting against a stock. And, of [...]

“This $3 Utah Company Could ‘Bring Down’ OPEC”

Longtime readers of this space might recognize the gist of this teaser just from that headline, but it has been reformulated and is getting pushed harder and harder of late, so I couldn’t resist another look at it. The ad is for the Oxford Club and their Communique, a relatively inexpensive newsletter (according to the [...]